SCHEMBL23964790

SCHEMBL23964790

CCC/C(N)=N\c1ccccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 9/20 0.49
▸ GRIN2D O15399 4/20 0.49
▸ GRIN3B O60391 4/20 0.49
▸ GRIN1 Q05586 4/20 0.49
▸ GRIN2A Q12879 4/20 0.49
▸ GRIN2B Q13224 4/20 0.49
▸ GRIN2C Q14957 4/20 0.49
▸ GRIN3A Q8TCU5 4/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ PABPC1 P11940 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ EBP Q15125 1/20 0.49
▸ TMEM97 Q5BJF2 1/20 0.49
▸ ESR1 P03372 1/20 0.43
▸ ESR2 Q92731 1/20 0.43
▸ CYP2C9 P11712 1/20 0.38
▸ ALPL P05186 1/20 0.37
▸ ALPG P10696 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1931049 0.76 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7435471 0.76 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13324586 0.76 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30084867 0.76 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7435475 0.76 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL23106523 0.75 SIGMAR1 (0.46) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL21794478 0.75 ESR2 (0.45) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL11234837 0.74 SIGMAR1 (0.56) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL22907397 0.71 MEN1 (0.31) MEN1KMT2A
SCHEMBL19258466 0.71 ESR2 (0.41) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901145-A1 DEUTERATED HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE SYNTHESIS OF IMAGING AGENTS F. Hoffmann-La Roche AG (CH) 2021-10-27 — — EP disclosed
Send feedback